T. solium IgM ELISA Kit

The T. solium IgM ELISA Kit is a semi-quantitative enzyme-linked immunosorbent assay (ELISA) designed to detect IgM antibodies to Taenia solium in human serum or plasma samples. This kit is intended for early detection of acute infections and must be used by trained medical technologists.

Cysticercosis is caused by the larval form (cysticerci) of T. solium and can infect various tissues, with the central nervous system (CNS) being the most commonly affected site. Infection of the brain can lead to neurocysticercosis, causing increased intracranial pressure, seizures, and altered mental states. Transmission occurs through the ingestion of T. solium eggs via contaminated food, water, or direct contact with infected individuals. While rare in industrialized countries, cysticercosis is endemic in Latin America, Asia, and Africa, with cases frequently reported among immigrants.

This kit uses microplates coated with T. solium crude antigens to detect specific IgM antibodies, providing reliable results through a colorimetric reaction. Results can be interpreted visually or with an ELISA reader, making this kit suitable for clinical diagnosis and epidemiological studies.

T. solium IgM ELISA Kit

√  Early Diagnosis: Detects IgM antibodies to identify acute infections.

√  High Sensitivity: Accurately detects low levels of IgM antibodies.

√  High Specificity: Reduces cross-reactivity with other parasitic infections.

√  Rapid Assay: Simplified workflow for quick and efficient testing.

√  Clear Readout: Strong colorimetric reaction for visual or instrumental interpretation.

√  Stable Storage: Reagents remain stable at 2-8°C for reliable use.

√  Quality Control: Includes positive and negative controls for validation.

√  Versatile Application: Compatible with both serum and plasma samples.

T. solium IgM ELISA Kit

√  Clinical Laboratories: Early screening and diagnosis of cysticercosis, including neurocysticercosis.

√  Public Health Centers: Epidemiological surveys and health screenings in high-risk populations.

√  Parasitology Research Institutions: Supporting studies on the immunology and pathology of cysticercosis.

√  Public Health Programs: Implementing disease prevention and control measures in endemic regions.

√  Remote Healthcare Facilities: Reliable diagnostic tools for underserved areas.

√  International Quarantine Services: Screening travelers from endemic regions.

√  Food Safety and Inspection Agencies: Monitoring contamination risks to prevent T. solium infections.